Sweden’s Affibody Inks Inmagene China R&D Pact

Affibody And Inmagene Will Focus On Auto-Immune Diseases

 
• By Sten Stovall
China_Sweden_Coins
Duo aim to commercialize ABY-035 targeting IL-17 • Source: Shutterstock

More from Deals

More from Business